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Abstract
The biotechnological research mainly emphasis its investigation on searching new natural 
drugs at economical to human welfare. With this view in mind, this research has focused 
to develop a prospective bioactive compound isolating from an efficient endophytic 
fungus isolated from potential medicinal tree Aegle marmelos. The endophytic fungus 
was isolated from the medicinal tree and identified as Aspergillus terreus FC36AY1. This 
fungus produced maximum of crude metabolites and this was produced in Sabouraud’s 
Dextrose Broth. The produced metabolites were extracted using acetone as a sole sol-
vent and it was taken for the assessment of antimicrobial and antioxidant analysis. The 
crude metabolites exhibited maximum activity at least concentration and further the 
crude extract were taken for purification processes through chromatographic techniques. 
Through purification, five different fractions were eluted and those five different frac-
tions were also assessed for antimicrobial and antioxidant analysis. From these analysis 
results, TA4 was found to be efficient fraction and it was characterized through FT-IR, 
GC-MS and UV-VIS analysis. The compound was taken for cytotoxicity determination 
in HT-29 cancer cells and anti-angiogenesis analysis was assessed through HET-CAM 
testing. The bio-activities study revealed that the compound TA4 has the ability to target 
the cancer cells in an efficient manner.
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1. Introduction
There are numerous natural pigments in the world. They are collected from the sources such 
as plants, animals and microorganisms. The uses of natural pigments are increasing world-
wide. The natural pigments have several affecting factors like temperature, pH, availability 
and cost. The natural pigments do not cause any serious health effects but it may cause some 
side effects only for the hypersensitivity persons. The natural pigments are also called as 
secondary metabolites in which the plants and microbes will produce in enormous by the 
metabolic production. Each living organism undergoes several pathways for the production 
of useful secondary metabolites. In this way the best and economical source is microbial 
metabolites and they have been extensively used in pharmaceutical and medicinal fields to 
treat various disorders and diseases. With this focus in mind, this research has been focused 
on the purification of secondary metabolites from an endophytic fungus which would be 
isolated from an efficient medicinal tree from biodiversified place.
Microbial pigment production is now one of the emerging fields of research to demonstrate its 
potential for various industrial applications. Among the molecules produced by microorgan-
isms are carotenoids, melanins, flavins, quinines and more specifically monascins, violacein 
or indigo. Industries are now able to produce some microbial pigments for applications in 
food, cosmetics and textiles. Naturally, pigment producing microorganisms like fungi, yeast 
and bacteria are quite common [1]. The pigments producing microorganisms will produce 
the antibiotic and inhibit the disease causing pathogens. Antibiotics eliminate or prevent the 
growth and can therefore cure disease caused by bacterial infection. They cannot however treat 
viral infection such as common cold or nonbacterial inflammation. Among the microbial pig-
ments the fungi placed a promising rank for its largest and efficient production of potential 
metabolites which could be applicable in different medicinal and pharmaceutical industries. To 
which, endophytic fungi explored an evidence in the production of medically used metabolites 
mainly from medicinal plants. An endophyte is an endosymbiont that lives within a plant for at 
least part of its life cycle without causing apparent disease [2]. Endophytes are ubiquitous and 
have been found in all species of plants however, most of the endophyte/plant relationships are 
not well understood [3]. Endophytes are also known to occur within lichens [4] and algae [5]. 
Many economically important grasses (e.g., Festuca sp. and Lolium sp.) carry fungal endophytes 
in genus Epichloë, some of which may enhance host growth [6], nutrient acquisition and may 
improve the plant’s ability to tolerate abiotic stresses, such as drought, and enhance resistance 
to insects, plant pathogens and mammalian herbivores. Nowadays the studies have focused on 
endophytic fungi isolated from medicinal tree. From ancient time onwards the medicines have 
been prepared from trees and plants in order to prevent/or cure the diseases. In this regard the 
current research has been focused on developing the medicine or drugs from the endophytic 
fungi residing in potential medicinal plants/or trees. These drugs are nothing but the metabo-
lites produced from the metabolic pathways by the organisms. As the endophytes (i) mimics 
the metabolism of the host plant, (ii) easy for industrial means and (iii) improvement in activity 
compared to host plant. The drug derived from endophytes explores the nature of the drugs 
derived from the medicinal plants and/or trees. The research will be discussed on the bioactive 
secondary metabolites produced by endophytic fungi through different production, and their 
usage in different medicinal fields as anti-angiogenic product.
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2. Materials and methods
2.1. Isolation and identification of endophytic fungi
The potential endophytic fungus was isolated from a prospective medicinal plant Aegle 
marmelos from Western Ghats (Nilgiris cluster), Coimbatore. This fungus was found to exhibit 
highest antagonistic activity when compared to other 37 different endophytic fungi from the 
medicinal plant. Further the potential fungus was named as FC36AY1 and identified to be 
Aspergillus terreus FC36AY1 with the NCBI accession number KY807648. The FC36AY1 was 
taken for the production of metabolites in Sabouraud’s Dextrose Broth (SDB) medium for 
17 days of incubation at stationary phase in normal cycle. The pigmented crude metabolites 
extract was extracted using acetone as sole solvent and it was concentrated for further use. 
The crude metabolites extract was assessed for biological determination such as antimicro-
bial and antioxidant analysis [7]. The fungus FC36AY1 manifested maximum activity at least 
concentration so this was taken for further purification process. The mass production of pig-
mented secondary metabolites was carried out in SDB medium and the yield was calculated 
according to Mani et al. [7]. The crude extract was taken for purification process to elute the 
bioactive secondary metabolite through chromatographic techniques.
2.2. Partial purification of the bioactive secondary metabolite
2.2.1. TLC
The crude extract was subjected to TLC (thin layer chromatography) [8]. About 5 μL of the 
crude extract was applied 1 cm above from the lower edge of the thin layer chromatography 
slides and dried. It was immersed to a depth of 1 cm in the solvents. The different solvent sys-
tem tested for movement of the pigment was chloroform:methanol and petroleum ether:ethyl 
acetate. The best solvent system for the separation of the components in the crude extract was 
taken. The solvent front was marked and R
f
 value was calculated.
2.2.2. High performance liquid chromatography (HPLC)
The active fraction was further purified through preparative high performance liquid chro-
matography (HPLC) (Shimadzu-1100 series), manual injector with quaternary pump, photo-
diode array detector equipped with C18 column (4.6 × 250 mm) with 5 μL of pore size with the flow rate of 1 mL/min and mobile phase of acetonitrile:H
2
O (80:20) at 427 nm.
2.3. Antioxidant activity
The purified fractions were taken for antioxidant analysis for determining the prospective 
secondary metabolite.
2.3.1. DPPH radical scavenging assay
The antioxidants present in fungal crude metabolites were aliquot into different concentra-
tions (20–100 μg) to determine extract’s ability to scavenge of 2,2-diphenyl-1-picrylhydrazyl 
Determination of In Vitro Cytotoxicity and Anti-Angiogenesis for a Bioactive Compound…
http://dx.doi.org/10.5772/intechopen.81046
15
(DPPH) radicals using the method of Mani et al. [7] in triplicates. DPPH solution (1 mM DPPH 
radical solution in 95% ethanol) was added to the crude metabolites extracts and made upto 
1 mL, vortexed well, and then incubated for 30 minutes in dark hood at room temperature. 
After incubation, the samples were poured into microfuge tubes and centrifuged for 5 min at 
13,500 rpm at RT. The absorbance of each sample at λ = 517 nm was measured and 1 mL of 
95% EtOH/MeOH was used as a control, and DPPH were used as reference compounds. The 
antioxidant activity is given as percent (%) DPPH scavenging assay was calculated using the 
formula: [(control absorbance − extract absorbance)/(control absorbance) × 100]. The fungi 
exhibiting the maximum antioxidant activity at minimum concentration and antagonistic 
profile were taken for further identification studies.
2.3.2. Reducing power assay
Total reducing power was determined as described by Oyaizu [9] in triplicates [7]. 1 mL of 
sample solution at different concentrations (20–100 μg) was mixed with 2.5 mL of phosphate 
buffer (0.2 mol/L, pH 6.6) and 2.5 mL of 1% potassium ferricyanide. The mixture was incu-
bated at 50°C for 20 min, 2.5 mL of 10% trichloroacetic acid (TCA) was added to the mixture 
and centrifuged at 3000 × g for 10 min. The supernatant (5 mL) was mixed with 1 mL of 
ferric chloride (0.1%), and the absorbance was measured at 700 nm in a spectrophotometer. 
Increased absorbance of the reaction mixture indicated increased reducing power.
2.3.3. Metal chelating activity
The metal chelating activity was analyzed by the method of Dinis et al. [10] with slight modi-
fication in triplicates [7]. The reaction was performed in HEPES buffer (20 mM) at pH 7.2. 
Various concentrations (20–100 μg) of samples were mixed with a solution of 12.5 μM ferrous 
sulfate solution. Addition of 75 μM ferrozine was to initiate the reaction and the mixture 
was shaken vigorously and incubated for 20 min at room temperature. After incubation the 
absorbance was measured at 562 nm. Ascorbic acid was used as the reference compound and 
the percentage chelating capacity was calculated as; % chelating activity = [(A0 − A1)/A0] × 100 
where, A0 = absorbance of the blank; A1 = absorbance of the sample.
2.3.4. Superoxide anion radical scavenging assay
Measurement of the superoxide anion radical scavenging capacity of the eluted fractions were 
essential according to the method described by Liu et al. [11] using a minor modification. The 
principle of this method is that superoxide radicals are generated in phenazine methosul-
fate (PMS)-nicotinamide adenine dinucleotide (NADH) systems by oxidation of NADH and 
reduction of nitroblue tetrazolium (NBT). In this experiment, the superoxide radicals were 
generated with 3.0 mL of Tris-HCl buffer (16 mM, pH 8.0) containing 1.0 mL of NBT (50 μM) 
solution, 1.0 mL NADH (78 μM) solution and samples of the compound MM4 (20–100 μg/mL) 
in methanol. The reaction was initiated by adding 1.0 mL of phenazine methosulfate 
(PMS) solution (10 μM) to the mixture. The absorbance at 560 nm was measured against a blank. 
Ascorbic acid was used as a standard. The scavenging activity was calculated by: [(Abs 
control − Abs sample)/Abs control] × 100.
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2.3.5. Hydroxyl radical scavenging assay
The scavenging activity for hydroxyl radicals recommended by Yu et al. [12] was followed 
with minor changes using the fractions. Reaction mixture contained 0.6 mL of 1.0 mM Deoxy 
ribose, 0.4 mL of 0.2 mM phenyl hydrazine, 0.6 mL of 10 mM phosphate buffer (pH 7.4). It was 
incubated for 1 h at room temperature. Then 1 mL of 2–8% TCA, 1 mL of 1% TBA and 0.4 mL 
of compound (at different concentrations) were added and kept in water bath for 20 min. The 
absorbance of the mixture at 532 nm was measured with a spectrophotometer. From the read-
ings, the hydroxyl radical scavenging activity was calculated as: [(Abs control − Abs sample)/
Abs control] × 100.
2.3.6. Chemical characterization of bioactive secondary metabolite
The bioactive purified fraction which evinced maximum antioxidant activity at least concen-
tration was dissolved in acetone and it was taken for UV-analysis using UV-Vis scanning spec-
troscopy for the detection of single peak. Scanning was performed between 200 and 800 nm 
wavelength. Later the fraction was subjected to structural elucidation of the compound. 1 mg 
of purified fraction was dried and analyzed for Infrared (IR) spectra using FTIR spectroscopy. 
The important IR bands of symmetric and asymmetric stretching and stretching frequencies 
were studied to determine the presence of functional groups.
The gas chromatography-mass spectrometry was done by advanced equipment (Thermo 
GC—Trace ultra VER: 5.0, Thermo MS DSQ II). The column used in this experiment was DB 
5-MS capillary standard non-polar column with the dimension of 30 mts, ID-0.25 mm and the 
film was 0.25 μm. The carrier gas used was helium, with the flow rate at 1.0 mL/min and the 
temperature was as oven temperature 70°C which was raised to 260°C at 6°C/min. The sample 
of 1 μL which was purified from HPLC analysis was taken and injected for the experiment.
2.4. In vitro studies
2.4.1. MTT assay
The cytotoxic effect of the bioactive compound was studied using cancer cell lines. The HT-29 
cell line was obtained from National Centre for Cell Sciences, Pune (NCCS). The cells were 
maintained in Minimal Essential Medium supplemented with 10% FBS, penicillin (100 U/mL), 
and streptomycin (100 μg/mL) in a humidified atmosphere of 50 μg/mL CO
2
 at 37°C. Cells 
(1 × 105/well) were plated in 24-well plates and incubated in 37°C with 5% CO
2
 condition. 
After the cell reaches the confluence, the various concentrations of the samples were added 
and incubated for 24 h. After incubation, the sample was removed from the well and washed 
with phosphate-buffered saline (pH 7.4) or MEM without serum. 100 μL/well (5 mg/mL) of 
0.5% 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-tetrazolium bromide (MTT) were added and 
incubated for 4 h. After incubation, 1 mL of DMSO was added in all the wells. The absor-
bance at 570 nm was measured with UV-Vis Spectrophotometer using DMSO as the blank. 
Measurements were performed and the concentration required to inhibit 50% of cells (IC50) 
was determined graphically. The % cell viability was calculated using the following formula 1:
Determination of In Vitro Cytotoxicity and Anti-Angiogenesis for a Bioactive Compound…
http://dx.doi.org/10.5772/intechopen.81046
17
  %cell viability =  ( A 570 of treated cells /  A 570 of control cells × 100) (1)
Graphs were plotted using the % of cell viability as Y-axis and concentration of the sample 
in X-axis. Cell control and sample control was included in each assay to compare the full cell 
viability in cytotoxicity assessments.
2.5. Determination of HET-CAM test [Hen’s egg test on the chorio-allantoic 
membrane (HET-CAM) of chick eggs]
In order to understand the inflammatory tissue reactions of metabolite coated materials on the 
live tissues, the materials were placed on the surface of Chorio-Allantoic membrane (CAM) of 
embryonated chick eggs. The inflammatory response on CAM was evaluated by direct evalu-
ation method. Freshly laid fertile eggs were collected from the chicken farm and incubated 
at 36–37°C for 8 days before implanting (implantation day: 9th day) the sample materials 
such as compound TA4, acetone, positive and negative solutions. During the incubation time, 
the eggs were turned twice daily. On the day of implantation (9th day after laid), the eggs 
were candled to determine the position of the air sac and the embryo. A square, with sides 
approximately 18–20 mm, was marked on the shell where the chorio-allantoic membrane was 
best developed. Using a dental drill fitted with a straight hand-piece the sides of the marked 
square were drilled. In one corner of this large triangle a second smaller square was drilled, 
with sides of approximately 5 mm. A small slit was drilled in the shell over the air sac.
2.5.1. Application of test sample, solvent, positive and negative control on CAM
Aseptic technique was used for the implantation of the test sample on biomaterial as filter 
paper discs. For dropping the material onto chorio-allantoic membrane the egg was mounted 
on a stand, with the drilled area of shell uppermost; a straight Hagedorn’s needle was 
gently inserted under one corner of the smaller square of shell and this square was raised 
and removed. The shell and shell membrane circumscribed by the larger square were then 
removed, and the sterile pre-measured size of sample was inserted and carefully lowered on 
to the exposed membrane. In order to implement the implanted sample TA4, 0.3 mL of the 
substance (positive and negative control) was applied to the surface of the CAM on separate 
eggs. 0.1 N NaOH was added on the CAM of separate egg as a positive control and 0.9% NaCl 
was used as an appropriate negative control. After a 20-s exposure period, the CAM is rinsed 
with 5 mL of water.
2.5.2. Direct evaluation of CAM time for development of observed endpoints after exposure to 
the test substance
A procedure used to evaluate the time for development of endpoints after exposure to the 
test substance was to continually observe the CAM during the 5-min observation period and 
record (typically in seconds) the time at which each of the endpoints developed. Therefore, 
two separate time values (after 2 and 18 h of incubation) were obtained and recorded for each 
egg (one time value for each endpoint).
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3. Results
3.1. Purification of secondary metabolite
3.1.1. Thin layer chromatography
The concentrated crude metabolite extract was subjected to thin layer chroamtography and 
the best solvent system which separated maximum compounds as band was chloroform:me
thanol:toluene:acetic acid and at 95% about five visible bands got separated (Figure 1a)—R
f
 
value was calculated for obtained peaks and tabulated (Table 1).
3.1.2. High performance liquid chromatography (HPLC)
The crude extract was forced for preparative HPLC analysis about 6 different peaks were 
obtained at 427 nm (Figure 1b) and this range corresponds to the result of UV spectrum analy-
sis. The eluted fractions from HPLC analysis were assessed for antimicrobial profile. Among 
the five fractions (TA1–TA5), fraction 4 (TA4) was found to contain highest antimicrobial pro-
file on comparing to other fractions (Table 2). The fraction 4 explored highest activity against 
C. albicans, K. pneumoniae, E. coli, S. epidermidis and S. typhi. From these results it is evident that 
this particular fraction was able to control the growth of gastro intestinal and skin pathogens.
3.2. Determination of antioxidant properties
3.2.1. DPPH radical scavenging activity
The bioactive compound of the present study showed a concentration dependent antiradical 
activity by inhibiting DPPH radical (Figure 2a). The decrease in absorbance of the DPPH radical 
Figure 1. (a) TLC of crude extract and (b) chromatogram showing different peaks in Aspergillus sp. extract.
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caused by antioxidant was due to the scavenging of the radical by hydrogen donation. It is visu-
ally noticeable as a color change from purple to yellow. Also, a lower value of IC50 (concentra-tion at which the 50% scavenging activity is obtained) indicates a higher antioxidant activity at 
lower concentration. The IC50 concentration of purified fraction was found to 56 μg/mL.
3.2.2. Reductive power ability
The reducing ability of a bioactive compound generally depends on the presence of reduc-
tones, which exert the antioxidant activity by breaking the free radical chain by donating a 
S. no. Pathogens Zone of inhibition (in cm)
TA1 TA2 TA3 TA4 TA5
1 Staphylococcus aureus 0.5 0 1.2 1.2 1.2
2 Klebsiella pnuemoniae 0 0 0.9 1.4 0.9
3 Staphylococcus epidermis 0.9 0 0.8 1.6 0
4 Pseudomonas aeruginosa 1.1 0 1.2 1.1 0
5 Enterococcus faecalis 1.2 0 2.1 2.1 0
6 Bacillus subtilis 1 0 0 2.3 1.3
7 E. coli 0 0 0 1.0 1.2
8 Proteus mirabilis 0 0 1.1 0.9 0.9
9 Shigella sp 0 0 0.9 0 0.7
10 Salmonella 0 0 0 0 0.8
11 Candida albicans 0 0 0 2.1 0.9
12 Aspergillus terreus 2.1 0 0 2.3 0
<0.5 cm: no inhibition activity.
Table 2. Antimicrobial activity for eluted fractions.











 value of TLC for crude extract.
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hydrogen atom. In this study, the reductive ability of the compound TA4 had a maximum 
reductive power and this was observed by increasing OD units (Figure 2b). This confirmed 
the increasing reducing power through increasing OD units. When compared to the standard 
ascorbic acid, TA4 exerted a similar activity. This activity was concurrent with the investiga-
tion of ***Liu et al. (2007) with the same concentration of 20–100 μg/mL.
3.2.3. Superoxide radical scavenging activity
The superoxide radicals are generated by PMS and it was assessed using NBT. Figure 2c 
explains that the bioactive compound has a maximum scavenging mechanism at minimum 
concentration. The 50% of inhibition concentration value was found to be 24 μg/mL. The IC 50 concentration of purified fraction was found to 68 μg/mL.
3.2.4. Hydroxyl radical scavenging activity
Hydroxyl radical scavenging assay showed the ability of the bioactive compound and stan-
dard ascorbic acid in inhibiting hydroxyl radical mediated deoxyribose degradation in a Fe3+ 




 reaction mixture (Figure 2d). The IC50 value of the compound 
was found distinctly increased with increased concentration when compared to the standard. 
Hydroxyl radicals are the major active oxygen species causing enormous biological damage by 
lipid peroxidation in cells. The IC50 concentration of purified fraction was found to 75 μg/mL.
3.2.5. Metal chelating activity
The rate of color reduction was measured which was used in the estimation of chelating activ-
ity of the coexisting chelator. In the current analysis, the absorbance of Fe2+ ferrozine complex 
was decreased in a dose dependent manner which can be meant in other way as the activity 
increased with the increasing concentration from 20 to 100 μg/mL and the IC50 concentration of purified fraction was found to 70 μg/mL (Figure 2e).
Figure 2. (a) DPPH radical scavenging activity, (b) reductive power ability of purified fraction, (c) superoxide radical 
scavenging activity, (d) hydroxyl radical scavenging activity, and (e) metal chelating activity.
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3.3. Chemical characterization of the secondary metabolite
UV-Visible spectrum of the purified pink colored compound was recorded using acetone 
solution in the range of 200–700 nm showed a single peak for the purified fraction (Figure 3a). 
The spectral measurement showed that the compound had registered its absorption band in 
the region 427 nm. The peak in the wavelength of 427 nm showed that this is the active frac-
tion. IR spectrum has proven to be the most effective way to give the information about the 
functional groups present in the compound.
Figure 3b depicted the FT-IR report for the purified fraction. In that, the stretching frequencies 
of the IR spectrum recorded the highest peak at 1711.92 which correspond to C▬O (carbonyl/
ketone) stretching. The region 1360.41 denotes the region ▬C▬H (sp3 configuration and 
alkane group) and the region 1221.06 records CN stretching (aromatic primary amine group 
or phenolic group). The region 1426.80 and 1093.19 denotes ▬C▬H (sp3 configuration with 
vinyl C▬H) and C▬O (alcohol group) respectively. The frequencies from 3600 to 3200 cm−1 
denoted the alcohol group present in the compound and in the same way the frequencies 
recorded from 3000 to 2850 cm−1 denoted the alkane stretching.
3.3.1. GC-MS analysis
The gas chromatography-mass spectrometry (GC-MS) was analyzed for purified fraction of 
TA4. The chromatogram was obtained with 4 major peaks in TA4 (Figure 3c and d). Finally 
from the results of UV-spectra, FT-IR, GC-MS, analysis we conclude the compound of TA4 
was found to be octadecenoic acid 4-hydroxy methyl ester C19H38O3.
Figure 3. (a) UV-VS of TA4, (b) FT-IR spectra for TA4, (c) GC-MS of TA4, and (d) GC-MS RA peak of TA4.
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3.4. In vitro studies
3.4.1. MTT assay
The present investigation has been carried out for a potential bioactive compound TA4. 
The studies have been performed on HT-29 colon cancer cell lines with the control of triton 
X 100 (Table 3 and Figure 4). This result was similar to the investigation of Yuvaraj et al. 
[13] reported the IC50 at nearest concentration. The present study has showed that A. terrus 
FC36AY1 acetonic fractions could extensively inhibited cell proliferation architecture in dose 
dependent manner. This report demonstrating the in vitro anticancer activity of the TA4 from 
methanolic extract of A. terrus FC36AY1 providing a scientific basis for its effects on human 
health which is similar to Yuvaraj et al. [13], TA4 was found to be inhibited maximum number 
of cells. So TA4 was taken for further studies.







Table 3. MTT assay.
Figure 4. MTT analysis of TA4.
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Sample For 2 h For 18 h
No. of vessels in 
untreated CAM
No. of vessels in 
treated CAM
No. of vessels in 
untreated CAM




18 10 18 05
Sample—1–200 μL 12 10 12 08
Sample—1–400 μL 10 05 13 03
Positive 
control—NaOH
11 11 11 11
Table 4. Anti-angiogenesis effect of TA4 in HET-CAM test.
Figure 5. HET-CAM test on chick embryo control.
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3.5. HET-CAM test on chick embryo
The CAM assay is a perceptive, easily feasible, and cheap in vivo check for enquiries of the 
anti-angiogenic promise of individual compounds. The compound TA4 inhibited the angio-
genesis at an interval of 2 and 18 h (Table 4 and Figure 5). This evinced that the compound has 
the good anti-angiogenic potentiality which could be explored as anticancer agents.
4. Discussion
In our current scenario there are many new and interesting bioactive metabolites applied as anti-
biotics, antiviral, anticancer and antioxidant compounds, which are of pharmaceutical, industrial 
and agricultural importance. Those have been investigated, reported and characterized from sev-
eral fungal endophytes especially from medicinal plants/trees. Endophytic fungi have the ability 
to pulse up a plethora of secondary metabolites, typically dependent on the stage of development 
and environmental factors ranging from nutrient concentrations to light and temperature. The 
biosynthesis of pigmented secondary metabolite(s) is directly related to cultural conditions that 
include biomass in the production phase and duration of the incubation periods [14].
An investigation of Strobel and Daisy [15] suggested the endophytic fungi since such plants 
may harbor unique and rare endophytes capable of producing important bioactive metabo-
lites with multiple applications. First and foremost pharmaceutical applied drug Taxol, an 
anticancer drug was derived from Taxus, a gymnosperm is an important anticancer plant. 
Several endophytic fungi isolated from Taxus spp., worldwide have been reported to produce 
important bioactive metabolites [16, 17]. This current investigation is focused to produce 
the pigmented crude secondary metabolites and purify a bioactive compound through the 
antioxidant assessment which could be taken for anticancer applications by in vitro and in 
vivo studies. The isolated and identified endophytic fungus FC36AY1 was a prospective and 
potential strain on analyzing antagonistic and preliminary antioxidant analysis. The fungus 
explored highest activity in both the assessment. The antagonism revealed the extent of this 
analysis ability increased as the endophytic fungal colonies matured when compared to 
immature colonies. The significant inhibition in the growth of fungi without direct contact 
of mycelia suggests that the prevailing antagonisms may be due to the production of inhibi-
tory substances by the fungi or due to the competition for nutrients or both [18]. However, 
the mechanisms of inhibition in colony growth of the tested fungi were not addressed in 
our studies. This was similar to the investigation of Tayung et al. [17] investigated an endo-
phytic fungus Fusarium sp. with highest antimicrobial and antioxidant analysis isolate from 
India. The potential strain was taken for the identification which showed up the organism 
was Aspergillus terreus FC36AY1 with the NCBI BankIt ID accession number was KY807648.
The study focused to produce the mass cultivation of pigmented crude secondary metabolites 
using SDB as production medium on which the strain FC36AY1 produced about 2.31 U/g in 
1 L of production medium. The produced crude pigments were extracted using acetone as sole 
solvent from the fungal mat (biomass). This was similar to the study of Mani et al. [7] which 
explored that the extraction of pigmented secondary metabolites was done only in mid polar 
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solvents. The crude pigmented metabolites were experimented for the purification process 
through HPLC analysis on which the crude was separated into 6 different fractions. Those frac-
tions were taken for the assessment of antimicrobial and antioxidant activities. The 4th fraction 
TA4 was found to scavenge more free radicals at minimum concentration in a dose dependent 
manner and this was similar to the investigation of Samaga et al. [19]. In living organisms, oxi-
dative stress created by reactive oxygen species (ROS) resulting from metabolism, in the form 




) and nitric oxide 
(NO) leads to conditions like cancer, stroke, myocardial infarctions, diabetes, septic and hemor-
rhagic shock, and neurodegenerative diseases by inducing biomolecular oxidations. Therefore, 
effective free radical scavenging molecules are needed by food and pharmaceutical industries. 
The fraction TA4 exhibited effective free radical scavenging activity comparable with that of 
BHA. The free radical scavenging activity of this particular fraction could be attributed to 
the presence of phenolic compounds [7]. This fraction was taken for the elucidation purpose 
through FT-IR and GC-MS analysis, on which TA4 showed similarity with 96–100% for the mass 
spectra of the compound and FT-IR exhibited the functional groups present in the compound 
and this was similar to the study of Liu et al. [11]. From this characterization, we found that 
the compound was octadecenoic acid 4-hydroxy methyl ester C19H38O3. This compound was 
taken for cytotoxicity analysis on HT-29 colon cancer cell lines, the compound TA4 explored its 
activity by showing a promising strategy of killing the cancer cells in an efficient manner. This 
was similar to the study of Devi and Prabakaran [20] in which they had experimented on four 
different cancer cell lines by using a potential bioactive compound from endophytic fungus.
The compound was taken for determination of anti-angiogenesis on chick embryo and this HET-
CAM test exhibited maximum anti-angiogenesis by inhibiting maximum number of blood ves-
sels. This manifesting that the compound TA4 has the ability to target the cancer cells and destruct 
by inhibiting the angiogenesis mechanism which is an important thing in oncology. The drug 
should have the ability to kill the cancer cells and also destruct the angiogenesis mechanism which 
could lead to metastasis i.e., taking the cancer cells to other parts of the body through the blood 
vessels and colonize in some particular area of the human body. In this case, we have found a 
potential bioactive compound from an efficient endophytic fungus possessing the ability to target 
the angiogenesis and avoid the metastasis. This is the first report that a bioactive compound TA4 
from A. terrus FC36AY1 possessing the ability of anti-angiogenesis which was identified through 
HET-CAM analysis. From this investigation, we are concluding the compound TA4 evincing the 
ability to target the cancer cells and also it possess multi-functionality in medicinal fields.
5. Conclusion
The current scenario of the biotechnological research is searching for a new natural drug 
which could efficiently target on different diseases. This research mainly focuses on cancer 
study by isolating and characterizing a bioactive compound which exhibit its cytotoxicity 
and anti-angiogenesis against cancer cell lines. The compound TA4 manifested its charac-
teristics by exploring its activities in different analysis. Finally, this investigation concludes 
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